<DOC>
	<DOCNO>NCT00085098</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy work different way stop tumor cell divide stop grow die . It yet know whether radiation therapy alone effective chemotherapy plus radiation therapy treat germ cell tumor . PURPOSE : This randomized phase III trial study radiation therapy alone see well work compare chemotherapy radiation therapy treat patient newly diagnose primary CNS germ cell tumor .</brief_summary>
	<brief_title>Radiation Therapy Compared With Chemotherapy Radiation Therapy Treating Patients With Newly Diagnosed Primary Central Nervous System ( CNS ) Germ Cell Tumor</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare event-free survival overall survival patient newly diagnose primary CNS germ cell tumor treat conventional radiotherapy alone ( regimen A ) v chemotherapy follow tumor response-based radiotherapy ( regimen B ) . Secondary - Determine complete response rate patient treat regimen B . - Determine acute subacute toxicity regimen B patient . - Compare treatment-related morbidity , term verbal learn memory , executive functioning , quality life , patient treat regimen . - Determine prognostic value baseline serum , lumbar , intraventricular level human chorionic gonadotropin level patient treat regimen . - Determine prognostic value extent disease ( M+ vs modify M+ v M0 ) event-free survival overall survival patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord tumor location ( pineal v suprasellar v pineal + suprasellar ) , disease stage ( disseminate vs occult multi-focal v localize ) . Patients randomize 1 2 treatment regimen . All patient undergo operative procedure ( endoscopic biopsy , stereotactic biopsy , open craniotomy ) confirm diagnosis pure germ cell germinoma follow intraoperative perioperative staging evaluation . - Regimen A ( radiotherapy ) : Within 52 day surgery , patient undergo standard-dose radiotherapy daily day 1-5 approximately 5-6 week . - Regimen B ( chemotherapy plus radiotherapy ) : - Courses 1 2 : Patients receive carboplatin IV 1 hour day 1 2 etoposide IV 2 hour day 1-3 . Treatment repeat every 21 day 2 course . Patients achieve complete response ( CR ) proceed reduced-dose radiotherapy . Patients minimal residual disease ( MRD ) , partial response ( PR ) , stable disease ( SD ) receive chemotherapy course 3 4 outline . Patients progressive disease undergo second surgical procedure biopsy restaged . Patients confirm diagnosis germ cell tumor change tumor marker new lesion restaging proceed chemotherapy course 3 4 . - Courses 3 4 : Patients receive cisplatin IV 6 hour day 1 , cyclophosphamide IV 1 hour day 2 3 , filgrastim ( G-CSF ) subcutaneously IV begin day 4 continue blood count recover . Treatment repeat every 21 day 2 course . Patients achieve CR MRD proceed reduced-dose radiotherapy . Patients PR , SD , progressive disease restaged . Patients confirm diagnosis germ cell tumor restaging undergo standard radiotherapy regimen A . - Reduced-dose radiotherapy : Within 6 week start course 4 , patient undergo lower-dose radiotherapy daily day 1-5 5 week . Treatment regimens continue absence unacceptable toxicity event non-germinomatous germ cell tumor detect . Quality life neuropsychological function within domain intelligence , attention-concentration , memory , executive functioning assess 9 , 30 , 60 month diagnosis . Patients follow every 4 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 225 patient ( approximately 112 per treatment regimen ) accrue study within 5 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary CNS pure germ cell tumor Diagnosed within past 31 day Meets 1 OR none ( i.e. , M0 [ localize disease ] ) follow stag criterion : M+ ( disseminated disease ) Leptomeningeal intraventricular metastasis visualize MRI scan brain spine Clumps tumor cell lumbar cerebrospinal fluid ( CSF ) cytology Visible tumor stud wall lateral third ventricle note endoscopy surgery Primary tumor arise within parenchyma brain , brainstem , spinal cord Measurable multifocal tumor arise pineal suprasellar region ( i.e. , multiple midline tumor ) Infiltrative , intraaxial extension brain MRI &gt; 1 cm beyond enhance tumor Modified M+ ( occult multifocal disease ) M0 diagnosis localize pineal region tumor sign symptoms diabetes insipidus without measurable disease suprasellar region Lumbar CSF assay meet criterion follow marker profile : Serum CSF beta human chorionic gonadotropin ( βHCG ) ≤ 50 IU/dL Serum alpha fetoprotein ( AFP ) ≤ 10 IU/L AND ≤ institutional norm CSF AFP ≤ 2.0 IU/L AND ≤ institutional norm PATIENT CHARACTERISTICS : Age 3 25 Performance status Not specify Life expectancy Not specify Hematopoietic Absolute neutrophil count &gt; 1,000/mm^3 Platelet count &gt; 100,000/mm^3 ( transfusion independent ) Hemoglobin &gt; 10.0 g/dL ( transfusion allow ) Hepatic Bilirubin ≤ 1.5 time upper limit normal ( ULN ) aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 2.5 time ULN Renal Creatinine adjust accord age follows* : No great 0.4 mg/dL ( ≤ 5 month ) No great 0.5 mg/dL ( 6 month 11 month ) No great 0.6 mg/dL ( 1 year23 month ) No great 0.8 mg/dL ( 2 years5 year ) No great 1.0 mg/dL ( 6 years9 year ) No great 1.2 mg/dL ( 10 years12 year ) No great 1.4 mg/dL ( 13 year [ female ] ) No great 1.5 mg/dL ( 13 year 15 year [ male ] ) No great 1.7 mg/dL ( 16 year [ male ] ) AND Creatinine clearance OR radioisotope glomerular filtration rate &gt; 70 mL/min Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Euthyroid ( without levothyroxine sodium therapy ) determine normal T4 ± thyroidstimulating hormone levels* Diabetes insipidus allow provided patient relatively stable desmopressin acetate Normal endogenous cortisol function* Adequate antidiuretic hormone reserves* NOTE : *Unless receive replacement therapy PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Concurrent replacement hormone allow ( e.g. , corticosteroid , levothyroxine sodium , desmopressin acetate ) Radiotherapy Not specify Surgery Prior surgery germ cell tumor allow Other No prior therapy germ cell tumor Concurrent anticonvulsant allow</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>childhood central nervous system germ cell tumor</keyword>
</DOC>